跳至主要内容
临床试验/NCT05220319
NCT05220319
已完成
4 期

CORTERAS STUDY: The Effect of Corticosteroids on Early Recovery After Major Surgery in Elderly Patients

Ziekenhuis Oost-Limburg1 个研究点 分布在 1 个国家目标入组 751 人2022年2月16日

概览

阶段
4 期
干预措施
NaCl 0.9%
疾病 / 适应症
未指定
发起方
Ziekenhuis Oost-Limburg
入组人数
751
试验地点
1
主要终点
Post operative muscle weakness
状态
已完成
最后更新
3个月前

概览

简要总结

Major surgery induces a systemic inflammatory response, which can influence the post-operative morbidity, such as coagulation disorders and post-operative muscle weakness, hampering early recovery after surgery.

Single administration of high dose corticosteroids is known to reduce this inflammatory response and could possibly improve the post-operative outcome.

The CORTERAS study will evaluate the effect of administration of corticosteroids, as compared to no corticosteroids, on postoperative muscle weakness and quality of recovery after surgery in elderly patients.

详细描述

The number of elderly patients undergoing surgery is expected to increase in the coming years, due to the increase in life expectancy in the developing world. Compared to younger surgical patients, the older patients are at greater risk of mortality and morbidity after surgery. Post-operative fatigue is an important complication after surgery. Not only is it reported by patients as one of the most distressing symptoms, it is also thought to be a significant contributor to delayed recovery after surgery. From a pathophysiological point of view, muscle weakness could be a major contributor to this post-operative fatigue. Recent studies showed a profound reduction in muscle strength after surgery in elderly patients, which lasted for more than 3 months after surgery. This decrease in muscle strength might be induced by an excessive inflammatory response to surgery. Glucocorticosteroids are capable of tampering an excessive inflammatory response to surgery and could improve the quality of recovery after surgery. However, a possible effect on post-operative muscle weakness hasn't been specifically investigated. Therefore, the main objective of this prospective clinical trial is to evaluate the effect of corticosteroids on early post-operative outcome, focusing on muscle weakness, in elderly patients (≥60 years) undergoing surgery.

注册库
euclinicaltrials.eu
开始日期
2022年2月16日
结束日期
2025年10月28日
最后更新
3个月前
研究类型
Interventional
研究设计
Parallel
性别
All

研究者

责任方
Principal Investigator
主要研究者

Steven Thiessen

Principal Investigator

Ziekenhuis Oost-Limburg

入排标准

入选标准

  • Aged 60 years or older.
  • Scheduled for one of the predefined surgical procedures:
  • off-pump coronary bypass surgery
  • on-pump coronary bypass surgery
  • aortic and mitral valve replacement
  • laparoscopic hemicolectomies
  • thoracoscopic lung resections
  • femoral popliteal and tibial bypass surgery and femoral profundoplasty
  • laparoscopic radical prostatectomies

排除标准

  • Lack of informed consent or inability to give informed consent.
  • Severe postoperative nausea \& vomiting (PONV), needing corticosteroids as PONV prophylaxis.
  • Urgent, not elective surgery
  • Hypersensitivity or known allergic reactions to methylprednisolone
  • Preoperative systemic use of steroids:
  • Including, but not limited to, the use of corticosteroids \> 4 weeks before surgery of at least 4 mg methylprednisolone equivalents.
  • Excluding inhalational and topical steroids
  • Preexisting muscle disease o Including, but not limited to: Steinert's disease, amyotrophic lateral sclerosis (ALS), Duchenne dystrophy, amputation of dominant arm or hand.

研究组 & 干预措施

Placebo

100 ml of NaCl 0,9%, not containing corticosteroids, given at induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 100 ml of NaCl 0,9% will be administered at the beginning of CPB.

干预措施: NaCl 0.9%

Methylprednisolone

250 mg of methylprednisolone made up with 100 ml NaCl 0,9%, given at the induction of anaesthesia, before surgery. If a patient will receive cardiopulmonary bypass (CPB) during his operation, a repeat dose of 250 mg methylprednisolone will be administered at the beginning of CPB.

干预措施: Methylprednisolone

结局指标

主要结局

Post operative muscle weakness

时间窗: Pre-operative and Post operative day 1

decrease in muscle strength post-operatively, assessed by comparing the handgrip strength of the dominant hand, measured by the JAMAR dynamometer, on day 1 following surgery as compared to the preoperative value

次要结局

  • Post operative muscle weakness(Pre-operative and Post operative day 1, 3 and 5)
  • Maximum inspiratory pressure as measure of respiratory muscle function(Pre-operative and Post operative day 1, 3 and 5)
  • Post operative fatigue(Pre-operative and Post operative day 1, 3, 5 and 28)
  • Quality of recovery (QOR)(Post operative day 1, 3 and 5)
  • Functioning at day 28(Pre-operative and Post operative day 28)
  • Coagulation disorder(postoperatively first 24 hours)
  • Sleeping pattern(10 consecutive nights, starting 3 days before surgery)
  • Sleep quality(3 days before and 10 days after surgery)
  • Sleep chronotype(3 days before surgery)
  • Sleeping EEG pattern(first postoperative night)

研究点 (1)

Loading locations...

相似试验